Respiratory Flashcards
(71 cards)
Outline respiratory failure and the 2 types of RF
Respiratory failure: inability to maintain adequate oxygen levels or remove carbon dioxide
Type 1:
Low O2
Low/normal CO2
Type 2:
Low O2
High CO2 (retaining)
List some common causes of type 1 and type 2 respiratory failure
Type 1 RF:
- V/Q mismatch (PE, COPD, pneumonia, RDS newborn, pulmonary oedema)
- Diffusion defect (lung fibrosis)
- Intra-lung shunt (ARDS)
- Low atmospheric oxygen (high altitude)
- Right-to-left shunt (congenital heart defect)
Type 2 RF:
- Hypoventilation (many, including chest wall disorders, NM junction disorders)
- Increased carbon dioxide production
Outline the difference between acute and chronic respiratory failure
Acute:
- Needs urgent treatment
- May need artificial ventilation
- Minimal compensation by kidneys (bicarbonate levels)
Chronic:
- Slow onset and progression, allows for compensation
- Better tolerated, treatment is less urgent
- Compensation by kidneys (bicarbonate levels)
Outline how someone with respiratory failure presents (acute and chronic)
Acute:
- Respiratory symptoms e.g. SOB, cough, fever
- Drowsiness / coma
- Confusion
- Warm hands
- Bounding pulse
- Headache
Chronic:
- Mild vasodilation (pink puffers)
- May have no presenting features
List some investigations for suspected respiratory failure
ABG - gold standard for respiratory failure!
(gives pH, PaO2, PaCO2 and HCO3-)
May also do:
- Imaging e.g. chest x-ray
- O2 sats probe
List common causes of acute and chronic respiratory failure
Acute:
- Opioid overdose
- Head injury
- Severe acute asthma
Chronic:
- Severe COPD (can get acute exacerbations due to LRTI)
Outline the management steps for acute and chronic respiratory failure
ABCDE approach!
- Correct hypoxaemia/hypoxia with O2
- Nasal cannula
- Non-rebreathing mask
- Venturi mask - Correct hypercapnia / acidosis
- Correct underlying cause of hypercapnia if known
- Ventilatory support (non-invasive ventilation or intubation)
List some common asthma triggers
- Pet fluff
- Dust / dust mites
- Cold weather
- Exercise
- Pollution
- Cigarette smoke
- Pollen
- Damp
Describe the correct inhaler technique
- Hold inhaler with thumb underneath and finger on top
- Breathe out
Put inhaler into mouth, teeth on the plastic but don’t bite down, form a seal with your lips - Breathe in and press down on top
- Keep inhaling until lungs are full
- Hold breath for 10 seconds
May use spacer if their inhaler technique is ineffective
Outline occupational lung disease, including occupations that are associated with lung diseases and specific types of occupational lung disease
Can occur when there is long term exposure to hazardous / toxic / irritating particles or gases
Occupations:
- Factory workers
- Coal workers
- Farmers
- Worked with asbestos
- Industrial cleaners
- Labourers
Type:
- Coal workers’ pneumoconiosis (Black Lung Disease)
- Asbestosis (presents 20-30 yrs post exposure)
- Silicosis
- Farmers’ lung (allergic alveolitis)
Asbestosis - state the following:
- Pathophysiology
- Those at risk
- Presentation
- Investigations
- Management
Pathophysiology:
- Disturbing asbestos can lead to release of fine asbestos particles
At risk:
- Construction worker in 1970-1990s
- Builders/labourers working with older houses
Presentation:
- SOB
- Wheeze
- Chest pain
- Cough
- Fatigue
- Clubbing
Investigations:
- Lung function tests
- Chest x-ray
- CT scan
Management:
- No treatment once damage has occured
Can help
- Pulmonary rehabilitation
- O2 therapy
- Inhalers
- Stop smoking / don’t start smoking
- Ensure vaccinations up to date
Asthma (non-acute) - state the following:
- Pathophysiology
- Presentation
- Investigations
- Management
Pathophysiology:
- Chronic hypersensitivity condition caused by bronchoconstriction and leads to reversible airway obstruction
- Inflammatory response due to eosinophils, mast cells and Th2 cells
- Reversible on bronchodilators
Presentation:
- Wheeze
- SOB
- Dry (nocturnal) cough
- Chest tightness
- Atopic triad (asthma, eczema and hay fever)
- Family history of asthma
- Raised eosinophils
Investigations:
- PEFR
- Spirometry with reversibility with bronchodilators
- Fractional inhaled NO
Management:
NEW GUIDELINES
1. Low dose Fometerol/ICS as needed
2. Low dose Fometerol/ICS preventer
3. Moderate dose Fometerol/ICS preventer
4. Check FeNO level + eosinophil count
- If either raised: refer to specialist
- If normal, add LRTA e.g. Montelukast or LAMA e.g. Tiotroprium
(OLD GUIDELINES)
1. Short acting beta 2 agonists (SABA) e.g. Salbutamol
2. Inhaled corticosteroids (ICS) e.g. Beclomethasone
3. Leukotriene antagonists e.g. Montelukast
4. Long acting beta 2 agonists (LABA) e.g. Salmeterol
5. Increase ICS dose
6. Long acting muscarinic antagonists (LAMA) or Theophylline or increase ICS further
7. Refer to specialist
- Trigger avoidance
- Vaccinations up to date
- Yearly asthma review
- Avoid / stop smoking
Outline the chronic management of asthma for > 12 years (adults)
Management:
NEW GUIDELINES
1. Low dose Fometerol/ICS as needed
2. Low dose Fometerol/ICS preventer
3. Moderate dose Fometerol/ICS preventer
4. Check FeNO level + eosinophil count
- If either raised: refer to specialist
- If normal, add LRTA e.g. Montelukast or LAMA e.g. Tiotroprium
(OLD GUIDELINES)
1. Short acting beta 2 agonists (SABA) e.g. Salbutamol
2. Inhaled corticosteroids (ICS) e.g. Beclomethasone
3. Leukotriene antagonists e.g. Montelukast
4. Long acting beta 2 agonists (LABA) e.g. Salmeterol
5. Increase ICS dose
6. Long acting muscarinic antagonists (LAMA) or Theophylline or increase ICS further
7. Refer to specialist
- Trigger avoidance
- Vaccinations up to date
- Yearly asthma review
- Avoid / stop smoking
Outline the chronic management of asthma for 5-11 years
Management:
NEW GUIDELINES
1. Low dose ICS + SABA e.g. Salbutamol
2. Assess ability to use MART
- Suitable = low dose MART (ICS/Fometerol), increase to moderate dose if needed
- Unsuitable = ICS/LRTA e.g. Montelukast for a trial, then consider ICS/Fometerol
Outline the chronic management of asthma for < under 5
Management:
NEW GUIDELINES
1. Low dose ICS + SABA e.g. Salbutamol for 8-12 weeks
- If resolving symptoms, consider stopping ICS and monitor symptoms for 3 months
- If unresolving symptoms, refer to specialist
If symptoms return after 3 month break, restart ICS + SABA and titrate ICS dose up to moderate
Then consider adding LTRA as well
State the different severities of acute asthma:
- Mild
- Moderate
- Severe
- Life threatening
- Near fatal
Mild:
- PEFR > 75%
Moderate:
- PEFR 50-75%
Severe:
- PEFR 33-50%
- Can’t complete full sentences
- RR >25
- HR > 110
Life threatening:
- PEFR < 33%
- Sats < 92%
- Low RR or HR
- Cyanosis
- Silent chest
- Acute type 1 respiratory failure (low O2, low/normal CO2)
- Exhaustion
Near fatal:
- Acute type 2 respiratory failure (low O2, high CO2)
Outline the management for acute asthma
- Non-severe
- Severe
- Life threatening/fatal
ABCDE approach!
Non-severe:
- O2 therapy
- Nebulised Salbutamol (5mg)
- Oral Prednisolone 40mg (can use IV hydrocortisone)
Severe:
- Nebulised Ipratropium Bromide (500microg)
- Consider Salbutamol back-to-back
Life threatening/fatal:
- Urgent ITU/anaesthetist assessment
- CXR (portable)
- IV Aminophylline
What needs to be done to ensure safe discharge of a patient after asthma exacerbation
- PEFR > 75%
- 5 days oral Prednisolone
- 24 hrs without the use of nebulisers
Follow ups:
- Ensure asthma plan and PEFR tube
- Assess inhaler technique
- GP fu after 2 days
- Respiratory clinic after 4 weeks
COPD - state the following:
- Pathophysiology
- Presentation
- Investigations
- Management
Pathophysiology:
- Chronic obstructive non-reversible disease
- Either chronic bronchitis, emphysema or mixed
- Non-reversible with bronchodilators
- Associated with noxious particles (mostly smoking)
Presentation:
- Productive cough
- Wheeze
- SOB
- Periods of infective exacerbations
Investigations:
- Spirometry which shows non-reversibility with bronchodilators
Management:
- SMOKING CESSATION
- Pulmonary rehabilitation
- Inhalers (beta agonists and ICS)
- Mucolytics
- O2 therapy
- Up to date vaccinations
Outline the management for COPD exacerbations
ABCDE approch!
- O2 support
- Nebulisers - Salbutamol and Ipratropium
- Steroids (Prednisolone)
- Antibiotics if infective cause
- Consider IV Aminophylline
- Consider non-invasive ventilation or ITU referral if Type 2 RF
Outline how recommended guidelines for long term inhaler management for COPD patients differs in the following situtations:
- COPD with asthmatic features
- COPD with NO asthmatic features
Both: offer Salbutamol reliever inhaler
COPD with asthmatic features
- LABA and ICS e.g. Trimbow
(Formeterol and Beclometasone)
COPD with NO asthmatic features
- LABA and LAMA
List the common bacteria for pneumonia in:
- Community (CAP)
- Hospital (HAP)
- Atypical bacteria
Community (CAP)
- Strep pneumonia
- Haemophilus influenzae
- Moraxella catarrhalis
Hospital (HAP)
- MRSA
- E Coli
- Pseudomonas
Atypical bacteria - can’t be cultured or gram stained and don’t respond to Penicillins
- Legionella
- Mycoplasma pneumoniae
- Chlamydia pneumoniae
Pneumonia - state the following:
- Pathophysiology
- Presentation
- Chest examination findings
- Investigations
- Management
Pathophysiology:
- Infection of the lung parenchyma
- Chest x-ray abnormalities with respiratory symptoms
Presentation:
Symptoms
- SOB
- Fever
- Productive cough (yellow/green)
- Haemoptysis
- Pleuritic chest pain
- Fatigue/lethargy
Signs
- Low O2 sats
- Tachycardia
- Tachypnoea
- Hypoxia
- Hypotension
Chest examination findings:
- Bronchial breathing
- Coarse crackles
- Dullness to percussion
- May have reduced chest expansion
Investigations:
- Routine bloods (FBC, U&Es, CRP)
- Calculate CURB-65 score
- Chest x-ray
- Sputum culture (moderate/severe)
- Blood culture (moderate/severe)
- Legionella and pneumococcal urinary antigens (moderate/severe)
Management:
Mild: 5 days oral Abx
Moderate-severe: 7-10 days oral Abx (Flucloxacillin)
Outline the UHL recommended antibiotics for the following scenarios
Community acquired pneumonia (CAP):
- Mild
- Moderate
- Severe
Hospital acquired pneumonia (HAP):
- Mild
- Moderate
- Severe
Community acquired pneumonia (CAP):
Mild = Oral Amoxicillin (5 days)
Moderate = Oral Amoxicillin (5 days)
Severe = IV Co-Amoxiclav (5 days)
(Doxycycline second line)
Hospital acquired pneumonia (HAP):
Mild = Oral Co-Amoxiclav (5 days)
Moderate = Oral Co-Amoxiclav (5 days)
Severe = IV Co-Amoxiclav (5 days)
(Doxycycline second line)